Co‐Occurrence of Myasthenia Gravis and Facioscapulohumeral Muscular Dystrophy: A Case Series and Review of Literature
European Journal of Neurology · 2026
DOI: 10.1111/ene.70477 ↗At a glance
Übersichtsarbeit in European Journal of Neurology, 2026. Written by Giulia Tammam and 14 co-authors. Institution: Peripheral Nervous System & Muscle Department, Reference Centre for Neuromuscular Disorders, Pasteur 2 Hospital, Nice University Hospital, Nice, Fran…. Major MEDLINE topics: Muscular Dystrophy, Facioscapulohumeral, Myasthenia Gravis. Cited 2 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Background
Facioscapulohumeral dystrophy (FSHD) and Myasthenia Gravis (MG) are well‐known rare neuromuscular diseases of respectively genetic and acquired origin. Among muscular dystrophies, the co‐occurrence of MG with FSHD is the most common, representing a non‐negligible “double trouble”. Here, we aim to describe a series of patients with coexistence of these two rare disorders and combine this with a review of the literature to identify common elements which might provide useful clues when evaluating a FSHD patient with uncommon clinical presentation compatible with MG.
Methods
We retrospectively collected demographic, clinical, and laboratory data of patients affected by both FSHD and MG followed at the Nice University Center, and we performed a review of the literature.
Results
We identified 10 patients in our cohort, 7 females. All patients have a D4Z4 4qA allele of 7–10 RU, a disease onset > 45 years and a mean FSHD score of 9.6 ± 2 at the last evaluation. The mean age of onset of MG was 68.5 ± 7.6 years; all patients presented with anti‐AChR antibodies and without thymic pathology, and MG appeared in all but two patients after FSHD. We identified 9 case reports in the literature. All of them presented with AChR positivity. The majority of them presented with a late and very late onset MG and without thymic pathology.
Conclusions
Our results underline the need for careful clinical evaluation to identify uncommon features, especially in elderly FSHD patients carrying a D4Z4 4qA allele of 7–10 RU to exclude the coexistence of other treatable neuromuscular conditions.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Peripheral Nervous System & Muscle Department, Reference Centre for Neuromuscular Disorders, Pasteur 2 Hospital, Nice University Hospital, Nice, France.
- Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
- Clinical Genetics Unit, Department of Women's and Children's Health, University of Padova, Padova, Italy.
- Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
- Institute for Research on Cancer and Aging of Nice, CNRS, INSERM, Côte D'azur University, Nice, France.
ORCID profiles: Giulia Tammam, Yann David, Mihai-Bogdan Ioncea, Angela Puma, Jan J Verschuuren
Cite
APA
Tammam, G., Villa, L., Lemmers, R. J. L. F., Pini, J., Slioui, A., Bouchareychas, L., David, Y., Ioncea, M. B., Salviati, L., Cavalli, M., Ezaru, A., Puma, A., Verschuuren, J. J., van der Maarel, S. M., & Sacconi, S. (2026). Co‐Occurrence of Myasthenia Gravis and Facioscapulohumeral Muscular Dystrophy: A Case Series and Review of Literature. European Journal of Neurology. https://doi.org/10.1111/ene.70477
Vancouver
Tammam G, Villa L, Lemmers RJLF, Pini J, Slioui A, Bouchareychas L, et al. Co‐Occurrence of Myasthenia Gravis and Facioscapulohumeral Muscular Dystrophy: A Case Series and Review of Literature. European Journal of Neurology. 2026. doi:10.1111/ene.70477
BibTeX
@article{Tammam2026,
author = {Tammam, Giulia and Villa, Luisa and Lemmers, Richard J L F and Pini, Jonathan and Slioui, Abderhmane and Bouchareychas, Laura and David, Yann and Ioncea, Mihai-Bogdan and Salviati, Leonardo and Cavalli, Michele and Ezaru, Andra and Puma, Angela and Verschuuren, Jan J and van der Maarel, Silvère M and Sacconi, Sabrina},
title = {Co‐Occurrence of Myasthenia Gravis and Facioscapulohumeral Muscular Dystrophy: A Case Series and Review of Literature},
journal = {European Journal of Neurology},
year = {2026},
doi = {10.1111/ene.70477}
}
EUVIMED